The FDA approved the first at-home screening test for cervical cancer on May 9, a move experts anticipate will help boost screening rates across the country. Five notes: 1. The test kit is made by ...

The US Food and Drug Administration (FDA) has Approved first and only self-collection At-Home Cervical Cancer Screening ...

The FDA has approved Teal Wand™, the first self-collection device for cervical cancer screening that can be used at home.

Hims, Keeps and other companies advertise topical finasteride with limited disclosures of side effects.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Novo Nordisk partners with telehealth ...

FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.

Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...

The US Food and Drug Administration (FDA) has secured approval to Teal Health’s at-home vaginal sample self-collection device ...

Deals with Hims & Hers, LifeMD and Ro follow dismissal of a lawsuit that challenged the FDA's determination Wegovy is no ...

Fact checked by Nick Blackmer A prescription topical hair loss medication may cause lasting side effects that include ...

In clinical trials, the accuracy of self-testing with Teal’s wand matched that of a cancer screening performed in a doctor’s ...

The FDA has issued an important alert regarding ... fueled largely by the convenience of telehealth services. Topical finasteride works by inhibiting the conversion of testosterone into ...